{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:31:54Z","timestamp":1777660314677,"version":"3.51.4"},"reference-count":20,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HAB"],"published-print":{"date-parts":[[2019,4,2]]},"DOI":"10.3233\/hab-180353","type":"journal-article","created":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T11:47:04Z","timestamp":1545997624000},"page":"99-104","source":"Crossref","is-referenced-by-count":6,"title":["Investigation of LPA sequence variants rs6415084, rs3798220 with conventional coronary artery disease in Iranian CAD patients"],"prefix":"10.1177","volume":"27","author":[{"given":"Borzu","family":"Rouhani","sequence":"first","affiliation":[{"name":"Department of Genetic, Faculty of Science, Tonekabon Branch, Islamic Azad University, Tonekabon, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayyed Mohammad Hossein","family":"Ghaderian","sequence":"additional","affiliation":[{"name":"Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zivar","family":"Salehi","sequence":"additional","affiliation":[{"name":"Department of Biology, Faculty of Sciences, University of Guilan, Rasht, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"2","key":"10.3233\/HAB-180353_ref1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ahj.2004.09.025","article-title":"Heart disease epidemic in Pakistan: Women and men at equal risk","volume":"150","author":"Jafar","year":"2005","journal-title":"Am. Heart J"},{"issue":"6","key":"10.3233\/HAB-180353_ref2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MOL.0000000000000131","article-title":"What is the ultimate test that lowering lipoprotein(a) is beneficial for cardiovascular disease and aortic stenosis","volume":"25","author":"Hung","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"10.3233\/HAB-180353_ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jjcc.2015.02.002","article-title":"Anti-inflammatory and immunemodulatory therapies for preventing atherosclerotic cardiovascular disease","volume":"66","author":"Yamashita","year":"2015","journal-title":"J Cardiol"},{"issue":"1","key":"10.3233\/HAB-180353_ref4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10557-016-6648-3","article-title":"Human genetics and the causal role of lipoprotein(a) for various diseases","volume":"30","author":"Kronenberg","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"issue":"11","key":"10.3233\/HAB-180353_ref5","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1194\/jlr.R071233","article-title":"Lipoprotein(a) as a cause of cardiovascular disease: Insights from epidemiology, genetics, and biology","volume":"57","author":"Nordestgaard","year":"2016","journal-title":"J Lipid Res"},{"issue":"3","key":"10.3233\/HAB-180353_ref6","doi-asserted-by":"crossref","first-page":"e0121582","DOI":"10.1371\/journal.pone.0121582","article-title":"Sequence Variation within the KIV-2 Copy Number Polymorphism of the Human LPA Gene in African, Asian, and European Populations","volume":"10","author":"Noureen","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.3233\/HAB-180353_ref7","doi-asserted-by":"crossref","first-page":"e0149427","DOI":"10.1371\/journal.pone.0149427","article-title":"Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism","volume":"11","author":"Sticchi","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.3233\/HAB-180353_ref8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ng.307","article-title":"New susceptibility locus for coronary artery disease on chromosome 3q22.3","volume":"41","author":"Deloukas","year":"2009","journal-title":"Nat. Genet"},{"issue":"6","key":"10.3233\/HAB-180353_ref9","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.amjcard.2013.05.009","article-title":"Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery disease","volume":"112","author":"Anderson","year":"2013","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.3233\/HAB-180353_ref10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s11886-013-0396-9","article-title":"Genetics of lipid traits and relationship to coronary artery disease","volume":"15","author":"Keenan","year":"2013","journal-title":"Curr Cardiol Rep"},{"key":"10.3233\/HAB-180353_ref11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2796.2012.02592.x","article-title":"Lipoprotein(a) \u2013 resurrected by genetics","volume":"273","author":"Kronenberg","year":"2013","journal-title":"J Intern Med"},{"key":"10.3233\/HAB-180353_ref12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/sj.ki.5002131","article-title":"In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients","volume":"71","author":"Frischmann","year":"2007","journal-title":"Kidney Int"},{"key":"10.3233\/HAB-180353_ref13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/joim.12207","article-title":"Genetic determination of lipoprotein(a) and its associationwith cardiovascular disease. Convenient does not always mean better","volume":"276","author":"Kronenberg","year":"2014","journal-title":"J Intern Med"},{"key":"10.3233\/HAB-180353_ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2017.01.024","article-title":"Genetic risk analysis of coronary artery disease in Pakistani subjects using a genetic risk score of 21 variants","volume":"258","author":"Shahid","year":"2017","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.3233\/HAB-180353_ref15","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S2213-8587(17)30096-7","article-title":"Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: A molecular and genetic association study","volume":"5","author":"Zewinger","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.3233\/HAB-180353_ref16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1476-511X-12-127","article-title":"Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention","volume":"12","author":"Li","year":"2013","journal-title":"Lipids Health Dis"},{"key":"10.3233\/HAB-180353_ref17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1476-511X-13-74","article-title":"LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography","volume":"13","author":"Santos","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.3233\/HAB-180353_ref18","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1161\/ATVBAHA.107.141291","article-title":"A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease","volume":"27","author":"Luke","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3233\/HAB-180353_ref19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.atherosclerosis.2008.07.019","article-title":"Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy","volume":"203","author":"Chasman","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.3233\/HAB-180353_ref20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCGENETICS.111.959601","article-title":"Genetic variants in the apolipoprotein(a) gene and coronary heart disease","volume":"4","author":"Li","year":"2011","journal-title":"Circ Cardiovasc Genet"}],"container-title":["Human Antibodies"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/HAB-180353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:22:08Z","timestamp":1777447328000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/HAB-180353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":20,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/hab-180353","relation":{},"ISSN":["1875-869X","1093-2607"],"issn-type":[{"value":"1875-869X","type":"electronic"},{"value":"1093-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,2]]}}}